The MMRF Blog - Multiple Myeloma Research Foundation

The MMRF Blog

Patient-Powered Precision

A must-read interview with our Founder Kathy Giusti, as she discusses the Harvard Business School Kraft Accelerator program and how it is working across all cancers to speed precision cures for patients. READ MORE

Posted: December 18, 2017

ASH 2017 - Day Four

Another ASH meeting has come to a close, but not without another exciting development in MM! This morning’s late-breaking abstract session (abstracts that highlight exciting and substantive studies with a high clinical impact) included data on the use of the monoclonal antibody Darzalex (daratumumab), which has been shown... READ MORE

Posted: December 12, 2017

ASH 2017 - Day Three

Dr. James Kochenderfer from the NIH presented the latest data on the anti-B-cell maturation antigen (BCMA) CAR-T cell therapy bb2121 (ABSTRACT 740). In his Phase 1 study of bb2121 in 21 patients with relapsed/refractory MM (many who had previously received 3 to 14 different regimens), Dr. Kochenderfer and colleagues showed... READ MORE

Posted: December 11, 2017

Page 2 of 8712345...102030...Last »